Capitol Health Ltd (ASX: CAJ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Capitol Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $266.49 million
P/E Ratio 44.92
Dividend Yield 3.77%
Shares Outstanding 1.07 billion
Earnings per share 0.006
Dividend per share 0.01
Year To Date Return 14.89%
Earnings Yield 2.23%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Capitol Health Ltd (ASX: CAJ)
    Latest News

    A man in a suit at a desk throws papers around onto the floor as he reads them.
    Broker Notes

    9 ASX shares Goldman Sachs tips to positively surprise this earnings season

    These shares could be ones to watch in August.

    Read more »

    Contented looking man leans back in his chair at his desk and smiles.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    Investors may want to check out these ASX shares that have just been named as buys...

    Read more »

    A little girl brings her mug of hot milk close to her mouth, ready to take a big sip.
    Investing Strategies

    The disappointing ASX sector now ready for a MASSIVE winter revival

    Did you just cough? Maybe this heavily discounted industry could be your cure for a sick portfolio.

    Read more »

    A worried man holds his head and look at his computer.
    Share Fallers

    Why Bega Cheese, Capitol Health, Centaurus Metals, and Seek shares are falling

    These ASX shares are having a tough time on Wednesday.

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Goldman Sachs has just slapped buy ratings on these ASX healthcare shares

    These healthcare shares could offer sizeable returns according to one broker.

    Read more »

    A man wearing a white coat holds his hands up and mouth open with joy.
    Healthcare Shares

    'Highly sought-after': 3 ASX healthcare shares ready to roar again

    Before the COVID-19 pandemic, this sector was going absolutely gangbusters. One expert reckons it's ready to rock again.

    Read more »

    A kid wearing a pilot helmet holds a paper plane up to the sky.
    Healthcare Shares

    79% upside: The 'frustrating' ASX share waiting to take off

    Sometimes the market just hasn't yet woken up to the actual performance or potential of a business.

    Read more »

    2 women looking at phone
    Investing Strategies

    2 ASX shares to buy that no one talks about

    Do you want your portfolio to perform better than the market? Well, you better do something different to the market!

    Read more »

    Ask a Fund Manager

    3 small-cap ASX shares that drove fund up 35% while the market plunged

    Ask A Fund Manager: 1851 Capital's Martin Hickson tells how his small and micro-cap portfolio managed to provide positive returns…

    Read more »

    Three people in a corporate office pour over a tablet, ready to invest.
    Dividend Investing

    3 ASX All Ords shares going ex-dividend on Wednesday

    These All Ords shares will soon be calling time on their upcoming dividends.

    Read more »

    A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
    Opinions

    2 little-known ASX shares that this fund manager says have 'strong' outlooks

    Wilson Asset Management is bullish about these two ASX shares, including IPH.

    Read more »

    Happy healthcare workers in a labs
    Cheap Shares

    'Simply too cheap' ASX share that could plough ahead in a recession: expert

    Healthcare is hot this month, but this particular stock is still down in the doldrums. One fund manager likes the…

    Read more »

    Frequently Asked Questions

    Yes, Capitol Health has historically paid two fully franked shareholder dividends a year.

    Capitol Health generally pays its dividends in April and October.

    Capitol Health Ltd listed on the ASX on 9 June 2006.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    06 Mar 2024 $0.0050 100.00% Interim 02 Apr 2024
    21 Sep 2023 $0.0050 100.00% Final 20 Oct 2023
    01 Mar 2023 $0.0050 100.00% Interim 31 Mar 2023
    21 Sep 2022 $0.0050 100.00% Final 21 Oct 2022
    03 Mar 2022 $0.0050 100.00% Interim 01 Apr 2022
    23 Sep 2021 $0.0050 100.00% Final 22 Oct 2021
    04 Mar 2021 $0.0050 100.00% Interim 01 Apr 2021
    24 Sep 2020 $0.0050 100.00% Final 23 Oct 2020
    05 Mar 2020 $0.0050 100.00% Interim 23 Oct 2020
    24 Sep 2019 $0.0050 100.00% Final 23 Oct 2019
    05 Mar 2019 $0.0050 100.00% Interim 03 Apr 2019
    26 Sep 2018 $0.0040 100.00% Final 25 Oct 2018
    02 Mar 2018 $0.0040 100.00% Interim 03 Apr 2018
    24 Sep 2014 $0.0050 100.00% Final 24 Oct 2014
    24 Mar 2014 $0.0040 100.00% Interim 24 Apr 2014
    23 Sep 2013 $0.0030 100.00% Final 25 Oct 2013
    22 Mar 2013 $0.0025 100.00% Interim 26 Apr 2013
    24 Sep 2012 $0.0020 100.00% Final 19 Oct 2012
    04 Apr 2012 $0.0020 100.00% Interim 20 Apr 2012

    CAJ ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Capitol Health Ltd

    Capitol Health Ltd (ASX: CAJ) is a provider of diagnostic imaging and related services to the Australian healthcare market. It oversees a network of around 60 medical imaging clinics around the country. The company's services include X-rays, ultrasounds, CT scans and MRIs, nuclear medicine, mammography/breast screening, bone densitometry, and other related services.

     

    CAJ Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    15 Mar 2024 $0.27 $0.02 8.16% 879,996 $0.24 $0.27 $0.24
    14 Mar 2024 $0.25 $-0.01 -3.92% 263,522 $0.26 $0.26 $0.25
    13 Mar 2024 $0.26 $0.01 4.00% 361,045 $0.25 $0.26 $0.25
    12 Mar 2024 $0.25 $-0.01 -3.92% 1,207,554 $0.26 $0.26 $0.25
    11 Mar 2024 $0.26 $-0.01 -3.77% 358,437 $0.26 $0.27 $0.26
    08 Mar 2024 $0.27 $0.01 3.85% 1,134,697 $0.26 $0.27 $0.26
    07 Mar 2024 $0.26 $-0.01 -3.77% 683,833 $0.27 $0.27 $0.26
    06 Mar 2024 $0.27 $0.01 3.92% 577,010 $0.25 $0.27 $0.24
    05 Mar 2024 $0.26 $0.00 0.00% 180,166 $0.26 $0.26 $0.26
    04 Mar 2024 $0.26 $-0.02 -7.41% 6,311,859 $0.27 $0.27 $0.25
    01 Mar 2024 $0.27 $-0.01 -3.64% 1,504,363 $0.27 $0.27 $0.26
    29 Feb 2024 $0.28 $0.00 0.00% 4,054,255 $0.28 $0.28 $0.27
    28 Feb 2024 $0.28 $0.01 3.70% 498,214 $0.27 $0.28 $0.27
    27 Feb 2024 $0.27 $0.00 0.00% 367,833 $0.27 $0.27 $0.26
    26 Feb 2024 $0.27 $0.01 3.85% 527,128 $0.27 $0.28 $0.26
    23 Feb 2024 $0.26 $-0.01 -3.77% 10,527,924 $0.26 $0.27 $0.26
    22 Feb 2024 $0.27 $0.01 3.85% 656,833 $0.26 $0.27 $0.25
    21 Feb 2024 $0.26 $0.00 0.00% 1,638,076 $0.26 $0.26 $0.26
    20 Feb 2024 $0.26 $0.01 3.92% 937,899 $0.26 $0.26 $0.25
    19 Feb 2024 $0.26 $0.00 0.00% 65,497 $0.26 $0.26 $0.25

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Nov 2023 Justin Walter Issued 2,651,653 $530,330
    Issue of securities. 6,996,657 Unquoted Performance Rights
    28 Aug 2023 Justin Walter Buy 2,286,865 $514,544
    Conversion of securities.
    28 Aug 2023 Justin Walter Exercise 2,286,865 $514,544
    Conversion of securities. 50,24,241 Rights
    28 Aug 2023 Justin Walter Cancelled 679,237 $152,828
    Cancellation of securities. 4,345,004 unquoted Performance Rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Andrew Demetriou Non-Executive ChairmanNon-Executive Director Nov 2014
    Mr Demetriou was Chief Executive Officer of the Australian Football League from 2003 until June 2014. He was the Managing Director of the Ruthinium Group, a dental implant business, and he currently remains a board member. Andrew has also served as Non-Executive Chairman of the Baxter Group, is a former Chairman of the Australian Multicultural Advisory Council.
    Mr Justin Samuel Walter Chief Executive OfficerManaging Director Jul 2019
    Mr Walter has over thirty years' wealth of experience in healthcare across public and private hospitals, GP and allied health clinics, and consulting along with management and leadership skills. He was Managing Director of ASX listed healthcare company Zenitas Healthcare, and has held senior roles managing hospitals for Healthscope, and Spotless Group's health sector.
    Ms Laura Nicole McBain Non-Executive Director Jul 2021
    Ms McBain joined Capitol Health with leadership experience having held roles of CEO / General Manager at Bellamy's Australia Limited, Managing Director of Maggie Beer Holdings Limited and Non-Executive Director of Export Finance Australia. She is currently Interim Managing Director and CEO for Lark Distilling Ltd and was a Non-executive Director from June 2020 to February 2022.
    Mr Richard John Loveridge Non-Executive Director Sep 2017
    Mr Loveridge served as a partner in the Corporate Group of Herbert Smith Freehills for more than 20 years and was Managing Partner of their National Corporate Group for 5 years. His experience includes capital raisings, mergers and acquisitions, joint ventures, shareholder agreements, company reorganisations, and corporate head office and advisory matters.
    Dr Kevin (Kai-Chung) Shaw Non-Executive Director Sep 2021
    Dr Shaw has training and experience in neuroradiology and musculoskeletal imaging. He is the current Director of Radiology and Nuclear Medicine atthe University Hospital, Barwon Health. He has completed his radiology training at Royal Melbourne Hospital. He is a past examiner for the Royal Australian and New Zealand College of Radiologists (RANZCR) and previously sat on the College's Anatomy Exam Review Panel.
    Ms Melanie Jaye Leydin Company Secretary Aug 2017
    -
    Melanie Jaye Leydin Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    National Nominees Limited 23,105,315 30.12%
    Citicorp Nominees Pty Limited 10,927,990 14.24%
    J P Morgan Nominees Australia Pty Limited 9,215,795 12.01%
    HSBC Custody Nominees (Australia) Limited 6,946,992 9.05%
    BNP Paribas Noms Pty Ltd <Drp> 3,100,000 4.04%
    Washington H Soul Pattinson And Company Limited 2,230,924 2.91%
    Idinoc Pty Ltd <J & R Conidi Family A/C> 2,162,897 2.82%
    Buttonwood Nominees Pty Ltd 1,677,223 2.19%
    Neweconomy Com Au Nominees Pty Limited <900 Account> 1,506,011 1.96%
    Nick Conidi Pty Ltd <Conidi Family A/C> 1,462,864 1.91%
    Gia Chau Pty Ltd 1,300,000 1.69%
    SMKA Super Pty Ltd <Sk Super Fund A/C> 1,129,113 1.47%
    BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 1,031,055 1.34%
    Mr Nicola Conidi + Mrs Giannina Conidi <Nick & Jan Conidi S/F A/C> 1,031,055 1.34%
    Ilina-Taranto Holdings Pty Ltd <Ilina Taranto Family A/C> 982,096 1.28%
    Nygupta Pty Ltd <Gupta Family A/C> 583,333 0.76%
    PCJL Pty Ltd <Pcjl Family A/C> 540,532 0.70%
    Tomandtar Nominees Pty Ltd <Dobrotwir Family A/C> 232,629 0.30%
    Teleah Pty Ltd <Jr Sauvey Super Fund A/C> 220,000 0.29%
    Stelhaven Smsf Pty Ltd <Stelhaven Super Fund A/C> 191,610 0.25%

    Profile

    since

    Note